AL
Alumis
ALMS·NASDAQS San Francisco CAFounded 202090 employees
Small CapbiotechPublicImmunologyDermatology
Platform: TYK2i
Market Cap
$1.5B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (ALMS)
Loading ALMS stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Niratinib | ALM-3686 | NDA/BLA | 1 | TIM-3 | Urothelial Ca | ||
| ALM-8546 | ALM-8546 | Phase 1/2 | 1 | MDM2 | WilmsPTSD |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)